Multifocal Choroiditis Complications (CNV) Treatment: A Case Report

Background Multifocal choroiditis is a condition characterized by intraocular inflammation and multifocal choroidal lesions occurring in the absence of any known ocular or systemic disease. Cystoid macular edema, subretinal fibrosis, and choroidal neovascularization are common causes of visual loss. Description of the case A 22 years old female patient presented with a 3-month history of painless, progressive decreasing vision (RE greater than LE) and metamorphopsia in her both eyes. She was previously diagnosed and treated for multifocal choroiditis 6 months ago, in one other center. Complete eye examination, fluoresceine angiography and OCT revealed the diagnosis of choroidal neovascular membrane (CNVM) as a result of Multifocal Choroiditis. The patient was treated in her both eyes with one combined intravitreal injection of Avastin (1.25mg/0.05ml) / Triamcinolon (4 mg/0.1ml), and 3 consecutive (every 4 weeks) intravitreal injections of Avastin (1.25 mg/0.05 ml). A close follow-up period of 11 months was completed. Conclusion We reported a patient suffering from choroidal neovascular membrane as a result of multifocal choroiditis, with both eyes treated with one combined intravitreal injection of Avastin (1.25mg/0.05ml) / Triamcinolon (4 mg/0.1ml), and 3 consecutive (every 4 weeks) intravitreal injections of Avastin (1.25 mg/0.05 ml). The treatment resulted safe and effective in increasing the visual acuity (LE greater than RE) and improving the central retinal thickness. No vision threatening complication was noticed.